Dec 4, 2019

Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples

British Journal of Cancer
Alexandre Ho-Pun-CheungEvelyne Lopez-Crapez


Triple-negative breast cancer (TNBC) has a worse prognosis compared with other breast cancer subtypes, and biomarkers to identify patients at high risk of recurrence are needed. Here, we investigated the expression of human epidermal receptor (HER) family members in TNBC and evaluated their potential as biomarkers of recurrence. We developed Time Resolved-Förster Resonance Energy Transfer (TR-FRET) assays to quantify HER1, HER2 and HER3 in formalin-fixed paraffin-embedded (FFPE) tumour tissues. After assessing the performance and precision of our assays, we quantified HER protein expression in 51 TNBC specimens, and investigated the association of their expression with relapse-free survival. The assays were quantitative, accurate, and robust. In TNBC specimens, HER1 levels ranged from ≈4000 to more than 2 million receptors per cell, whereas HER2 levels varied from ≈1000 to 60,000 receptors per cell. HER3 expression was very low (less than 5500 receptors per cell in all samples). Moderate HER2 expression was significantly associated with higher risk of recurrence (HR = 3.93; P = 0.003). Our TR-FRET assays accurately quantify HER1, HER2 and HER3 in FFPE breast tumour specimens. Moderate HER2 expression may represent a novel progn...Continue Reading

  • References41
  • Citations
  • References41
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Biological Markers
ErbB-2 Receptor
ERBB3 Receptor Protein-Tyrosine Kinase
Tumor Tissue Sample
Triple Negative Breast Neoplasms
Breast Diseases
EGFR protein, human
Recurrence (Disease Attribute)

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Mikiko HayashiKenichi Sugihara
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Cornelia LiedtkeLajos Pusztai
© 2020 Meta ULC. All rights reserved